Melatonin and its agonists: An update

65Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.

Abstract

The pineal hormone melatonin is able to shift the timing of circadian rhythms, including the sleep-wake cycle, and to promote sleep. Melatonin agonists with similar properties have therapeutic potential for the treatment of circadian rhythm sleep disorders. Depression is specifically targeted by agomelatine, which is also a serotonin-2C (5-HT2C) antagonist.

References Powered by Scopus

Health in a 24-h society

638Citations
N/AReaders
Get full text

The circadian basis of winter depression

373Citations
N/AReaders
Get full text

Invited review: Integration of human sleep-wake regulation and circadian rhythmicity

331Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Physiology and pharmacology of melatonin in relation to biological rhythms

299Citations
N/AReaders
Get full text

Neurobehavioral, health, and safety consequences associated with shift work in safety-sensitive professions

142Citations
N/AReaders
Get full text

Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders

100Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Arendt, J., & Rajaratnam, S. M. W. (2008, October). Melatonin and its agonists: An update. British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.108.050955

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 31

48%

Researcher 16

25%

Professor / Associate Prof. 11

17%

Lecturer / Post doc 6

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

45%

Agricultural and Biological Sciences 15

31%

Psychology 7

14%

Chemistry 5

10%

Save time finding and organizing research with Mendeley

Sign up for free
0